Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer von Lin, J.J., Liu, S.V., McCoach, C.E., Zhu, V.W., Tan, A.C., Yoda, S., Peterson, J., Do, A., Prutisto-Chang, K., Dagogo-Jack, I., Sequist, L.V., Wirth, L.J., Lennerz, J.K., Hata, A.N., Mino-Kenudson, M., Nardi, V., Ou, S.-H.I., Tan, D.S.-W., Gainor, J.F.

Volltext

Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression von Aguilar, E.J., Ricciuti, B., Gainor, J.F., Kehl, K.L., Kravets, S., Dahlberg, S., Nishino, M., Sholl, L.M., Adeni, A., Subegdjo, S., Khosrowjerdi, S., Peterson, R.M., Digumarthy, S., Liu, C., Sauter, J., Rizvi, H., Arbour, K.C., Carter, B.W., Heymach, J.V., Altan, M., Hellmann, M.D., Awad, M.M.

Volltext

ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research von Belli, C., Penault-Llorca, F., Ladanyi, M., Normanno, N., Scoazec, J.-Y., Lacroix, L., Reis-Filho, J.S., Subbiah, V., Gainor, J.F., Endris, V., Repetto, M., Drilon, A., Scarpa, A., André, F., Douillard, J.-Y., Curigliano, G.

Volltext

Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors von Hellmann, M.D., Kim, T.-W., Lee, C.B., Goh, B.-C., Miller, W.H., Oh, D.-Y., Jamal, R., Chee, C.-E., Chow, L.Q.M., Gainor, J.F., Desai, J., Solomon, B.J., Das Thakur, M., Pitcher, B., Foster, P., Hernandez, G., Wongchenko, M.J., Cha, E., Bang, Y.-J., Siu, L.L., Bendell, J.

Volltext

Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases von Vokes, E.E., Ready, N., Felip, E., Horn, L., Burgio, M.A., Antonia, S.J., Arén Frontera, O., Gettinger, S., Holgado, E., Spigel, D., Waterhouse, D., Domine, M., Garassino, M., Chow, L.Q.M., Blumenschein, G., Barlesi, F., Coudert, B., Gainor, J., Arrieta, O., Brahmer, J., Butts, C., Steins, M., Geese, W.J., Li, A., Healey, D., Crinò, L.

Volltext

Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial von Griesinger, F., Curigliano, G., Thomas, M., Subbiah, V., Baik, C.S., Tan, D.S.W., Lee, D.H., Misch, D., Garralda, E., Kim, D.-W., van der Wekken, A.J., Gainor, J.F., Paz-Ares, L., Liu, S.V., Kalemkerian, G.P., Houvras, Y., Bowles, D.W., Mansfield, A.S., Lin, J.J., Smoljanovic, V., Rahman, A., Kong, S., Zalutskaya, A., Louie-Gao, M., Boral, A.L., Mazières, J.

Volltext

Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50 von Gainor, J.F., Rizvi, H., Jimenez Aguilar, E., Skoulidis, F., Yeap, B.Y., Naidoo, J., Khosrowjerdi, S., Mooradian, M., Lydon, C., Illei, P., Zhang, J., Peterson, R., Ricciuti, B., Nishino, M., Zhang, J., Roth, J.A., Grishman, J., Anderson, D., Little, B.P., Carter, B.W., Arbour, K., Sauter, J.L., Mino-Kenudson, M., Heymach, J.V., Digumarthy, S., Shaw, A.T., Awad, M.M., Hellmann, M.D.

Volltext

Activity of the Hsp90 inhibitor luminespib among non-small-cell lung cancers harboring EGFR exon 20 insertions von Piotrowska, Z., Costa, D.B., Oxnard, G.R., Huberman, M., Gainor, J.F., Lennes, I.T., Muzikansky, A., Shaw, A.T., Azzoli, C.G., Heist, R.S., Sequist, L.V.

Volltext

Jacques Copeau's “The Spirit in the Little Theatre”: Contexts and Texts von Gainor, J. Ellen, Un, John

Volltext

Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancer von Schoenfeld, A.J., Antonia, S.J., Awad, M.M., Felip, E., Gainor, J., Gettinger, S.N., Hodi, F.S., Johnson, M.L., Leighl, N.B., Lovly, C.M., Mok, T., Perol, M., Reck, M., Solomon, B., Soria, J.-C., Tan, D.S.W., Peters, S., Hellmann, M.D.

Volltext

Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysis von Borghaei, H., Ciuleanu, T.-E., Lee, J.-S., Pluzanski, A., Caro, R. Bernabe, Gutierrez, M., Ohe, Y., Nishio, M., Goldman, J., Ready, N., Spigel, D.R., Ramalingam, S.S., Paz-Ares, L.G., Gainor, J.F., Ahmed, S., Reck, M., Maio, M., O’Byrne, K.J., Memaj, A., Nathan, F., Tran, P., Hellmann, M.D., Brahmer, J.R.

Volltext

Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice von Sequist, L.V., Heist, R.S., Shaw, A.T., Fidias, P., Rosovsky, R., Temel, J.S., Lennes, I.T., Digumarthy, S., Waltman, B.A., Bast, E., Tammireddy, S., Morrissey, L., Muzikansky, A., Goldberg, S.B., Gainor, J., Channick, C.L., Wain, J.C., Gaissert, H., Donahue, D.M., Muniappan, A., Wright, C., Willers, H., Mathisen, D.J., Choi, N.C., Baselga, J., Lynch, T.J., Ellisen, L.W., Mino-Kenudson, M., Lanuti, M., Borger, D.R., Iafrate, A.J., Engelman, J.A., Dias-Santagata, D.

Volltext

Granville Barker on Theatre: Selected Essays by Harley Granville Barker (review) von Gainor, J. Ellen

Volltext

MS01.01 Biological Mechanisms of Resistance von Gainor, J.

Volltext

Safety and activity of alectinib plus bevacizumab in patients with advanced ALK-rearranged non-small-cell lung cancer: a phase I/II study von Lin, J.J., Muzikansky, A., Kennedy, E., Kuberski, H., Stober, L.L., Wanat, A.C., Azzoli, C.G., Lennes, I., Sequist, L.V., Dagogo-Jack, I., Shaw, A.T., Gainor, J.F.

Volltext

P14.26 Diminished Efficacy of PD-(L)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma is Impacted by KRAS Mutation Status von Ricciuti, B., Arbour, K., Lin, J., Vajdi, A., Tolstorukov, M., Hong, L., Zhang, J., Vokes, N., Li, Y., Spurr, L., Cherniack, A., Recondo, G., Lamberti, G., Rizvi, H., Egger, J., Plodkowski, A., Khosrowjerdi, S., Digumarthy, S., Vaz, N., Park, H., Nishino, M., Sholl, L., Barbie, D., Altan, M., Heymach, J., Skoulidis, F., Gainor, J., Hellmann, M., Awad, M.

Volltext

Safety and anti-tumor effects of MAGE-A10c796 TCR T-cells in two clinical trials von Lam, V.K., Hong, D.S., Heymach, J.V., Blumenschein, G., Butler, M.O., Johnson, M., Creelan, B., Gainor, J.F., Govindan, R., Mudad, R., Neal, J., Brophy, F., Fang, F., Hyland, N., Holdich, T., Ma, Y., Trivedi, T., Norry, E., Amado, R.G.

Volltext

First Hand: Hand-Picked Music for Kids von Gainor, Barry J., MD

Volltext

Next generation ALK inhibitors and mechanisms of resistance to therapy von Gainor, J.

Volltext

Heterogeneity and Variation in Resistance Mechanisms Among 223 Epidermal Growth Factor Receptor–Mutant Non–Small Cell Lung Cancer Patients With > 1 Post-Resistance Biopsy von Piotrowska, Z, Stirling, K, Heist, R, Campo, M, Rizzo, C, Digumarthy, S.R, Lanuti, M, Fintelmann, F.J, Lennes, I, Farago, A, Gainor, J, Azzoli, C.G, Temel, J, Mino-Kenudson, M, Dias-Santagata, D, Corcoran, R, Shaw, A, Engelman, J.A, Hata, A, Sequist, L.V

Volltext